ENSC
ENSC
NASDAQ · Biotechnology

Ensysce Biosciences Inc

$0.30
0.00 (-1.40%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +12,704.2% upside
Low Target $25.94
Average Target $37.99
High Target $62.46
Current Price $0.30
Current
$0.30
Target
$37.99
$25.94 $37.99 avg $62.46
Scenario Analysis
Bear Case
$25.94
8,642.8%
Low target
Base Case
$37.99
+12,704.2%
Avg target
Bull Case
$62.46
+20,951.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$2.75
-89.2% from high
52-Week Low
$0.23
+29.0% from low
Target vs 52W High
$37.99
+1,281.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.1%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -12.3%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.1%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.5%